Thrombocytopenia in cardiac surgery: Diagnostic and prognostic importance;Trombocitopenia em cirurgia cardíaca: Importância diagnóstica e prognóstica

Brazilian Journal of Cardiovascular Surgery

Volumn 26, Issue 1, 2011, Pages 47-53

  Rezende, Ederlon ^a   Morais, Gustavo ^b   Silva Jr , João Manoel ^b   de Oliveira, Amanda Maria Ribas Rosa ^b   Souza, Jose Marconi Almeida ^a   Toledo, Diogo Oliveira ^b   Richter, Ivo ^b   Brandão, Enock Meira ^b  

^a State Civil Servant Hospital   (Brazil)

^b Cardiac Surgeon at the State Civil Servant Hospital of São Paulo   (Brazil)

Author keywords

Cardiovascular surgical procedures; Prognosis; Thrombocytopenia

Indexed keywords

ANTICOAGULANT AGENT; HEPARIN;

ARTICLE; FEMALE; HEART SURGERY; HUMAN; INCIDENCE; MALE; METHODOLOGY; MIDDLE AGED; MORTALITY; PROGNOSIS; PROSPECTIVE STUDY; RISK ASSESSMENT; THROMBOCYTOPENIA;

ANTICOAGULANTS; CARDIAC SURGICAL PROCEDURES; FEMALE; HEPARIN; HOSPITAL MORTALITY; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; RISK ASSESSMENT; THROMBOCYTOPENIA;

EID: 79959536395     PISSN: 01027638     EISSN: 16789741     Source Type: Journal    
DOI: 10.1590/S0102-76382011000100011     Document Type: Article

References (33)

1. Stéphan F, Hollande J, Richard O, Cheffi A, Maier-Redelsperger M, Flahault A. Thrombocytopenia in a surgical ICU. Chest. 1999;115(5):1363-70.
2. Baughman RP, Lower EE, Flessa HC, Tollerud DJ. Thrombocytopenia in the intensive care unit. Chest. 1993;104(4):1243-7.
3. Warkentin TE, Sheppard JA, Horsewood P, Simpson PJ, Moore JC, Kelton JG. Impact of the patient population on the risk for heparin-induced thrombocytopenia. Blood. 2000;96(5):1703-8.
4. Lee DH, Warkentin TE. Frequency of heparin-induced thrombocytopenia. In: Warkentin TE, Greinacher A, eds. Heparin-induced thrombocytopenia. 3rd ed. New York:Marcel Deckker;2004. p.107-48.
5. Giffhorn H, Rampielli A, Bonatelli Filho L, Collaço J. Trombocitopenia adquirida e cirurgia cardíaca: relato de caso. Rev Bras Cir Cardiovasc. 2002;17(2):166-70.
6. Shantsila E, Lip GY, Chong BH. Heparin-induced thrombocytopenia. A contemporary clinical approach to diagnosis and management. Chest. 2009;135(6):1651-64.
7. Kerendi F, Thourani VH, Puskas JD, Kilgo PD, Osgood M, Guyton RA, et al. Impact of heparin-induced thrombocytopenia on postoperative outcomes after cardiac surgery. Ann Thorac Surg. 2007;84(5):1548-53.
8. Gettings EM, Brush KA, Van Cott EM, Hurford WE. Outcome of postoperative critically ill patients with heparin-induced thrombocytopenia: an observational retrospective case-control study. Crit Care. 2006;10(6):R161.
9. Selleng S, Selleng K, Wollert HG, Muellejans B, Warkentin TE, Greinacher A. Heparin-induced thrombocytopenia in patients requiring prolonged intensive care unit treatment after cardiopulmonary bypass. J Thromb Haemost. 2008;6(3):428-35.
10. Oliveira GB, Crespo EM, Becker RC, Honeycutt EF, Abrams CS, Anstrom KJ, et al; Complications After Thrombocytopenia Caused by Heparin (CATCH) Registry Investigators. Incidence and prognostic significance of thrombocytopenia in patients treated with prolonged heparin therapy. Arch Intern Med. 2008;168(1):94-102.
11. Elalamy I, Le Gal G, Nachit-Ouinekh F, Lafuma A, Emery C, Le-Fur C, et al. Heparin-induced thrombocytopenia: an estimate of the average cost in the hospital setting in France. Clin Appl Thromb Hemost. 2009;15(4):428-34.
12. Smythe MA, Koerber JM, Fitzgerald M, Mattson JC. The financial impact of heparin-induced thrombocytopenia. Chest. 2008;134(3):568-73.
13. Hirsh J, Warkentin TE, Raschke R, Granger C, Ohman EM, Dalen JE. Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinectics, dosing considerations, monitoring, efficacy, and safety. Chest. 1998;114(5 Suppl):489S-510S.
14. Warkentin TE, Heddle NM. Laboratory diagnosis of immune heparin-induced thrombocytopenia. Curr Hematol Rep. 2003;2(2):148-57.
15. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med. 1985;13(10):818-29.
16. Vincent JL, de Mendonça A, Cantraine F, Moreno R, Takala J, Suter P, et al. Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on sepsisrelated problems of the European Society of Intensive Care Medicine. Crit Care Med. 1998;26(11):1793-800.
17. Marshall JC, Cook DJ, Christou NV, Bernard GR, Sprung CL, Sibbald WJ. Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome. Crit Care Med. 1995;23(10):1638-52.
18. Majerus PW, Broze GJ Jr, Miletich JP, et al. Anticoagulant, thrombolytic and antiplatelet drugs. In: Goodman LS, Gilman A, Rall TW, et al., eds. The pharmacological basis of therapeutics. 8th ed. New York:Pergamon Press;1990. p.1311.
19. Weismann RE, Tobin RW. Arterial embolism occurring during systemic heparin therapy. AMA Arch Surg. 1958;76(2):219-25.
20. Roberts B, Rosato FE, Rosato EF. Heparin: a cause of arterial emboli? Surgery. 1964;55:803-8.
21. Heijmans JH, Maessen JG, Roekaerts PM. Risk stratification for adverse outcome in cardiac surgery. Eur J Anaesthesiol. 2003;20(7):515-27.
22. Walls JT, Curtis JJ, Silver D, Boley TM. Heparin-induced thrombocytopenia in patients who undergo open heart surgery. Surgery. 1990;108(4):686-92.
23. Singer RL, Mannion JD, Bauer TL, Armenti FR, Edie RN. Complications from heparin-induced thrombocytopenia in patients undergoing cardiopulmonary bypass. Chest. 1993;104(5):1436-40.
24. Thong CL, Kam PCA. Heparin-induced thrombocytopenia. Curr Anaesth Crit Care. 2005;16(3):143-50.
25. Rice TW, Wheeler AP. Coagulopathy in critically ill patients: part 1: platelet disorders. Chest. 2009;136(6):1622-30.
26. Arepally GM, Ortel TL. Clinical practice. Heparin-induced thrombocytopenia. N Engl J Med. 2006;355(8):809-17.
27. Selleng S, Malowsky B, Strobel U, Wessel A, Ittermann T, Wollert HG, et al. Early-onset and persisting thrombocytopenia in post-cardiac surgery patients is rarely due to heparin-induced thrombocytopenia, even when antibody tests are positive. J Thromb Haemost. 2010;8(1):30-6.
28. Warkentin TE, Levine MN, Hirsh J, Horsewood P, Roberts RS, Gent M, et al. Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfracionated heparin. N Engl J Med. 1995;332(20):1330-5.
29. Ling E, Warkentin TE. Intraoperative heparin flushes and subsequent acute heparin-induced thrombocytopenia. Anesthesiology. 1998;89(6):1567-9.
30. Melo EI, Pereira MS, Cunha RS, Sá MPL, Mourão PAS. Controle da qualidade das preparações de heparina disponíveis no Brasil: implicações na cirurgia cardiovascular. Rev Bras Cir Cardiovasc. 2008;23(2):169-74.
31. Francis JL, Palmer GJ 3rd, Moroose R, Drexler A. Comparison of bovine and porcine heparin in heparin antibody formation after cardiac surgery. Ann Thorac Surg. 2003;75(1):17-22.
32. Gruel Y, Régina S, Pouplard C. Usefulness of pretest clinical score (4Ts) combined with immunoassay for the diagnosis of heparin-induced thrombocytopenia. Curr Opin Pulm Med. 2008;14(5):397-402.
33. Crowther MA, Cook DJ, Albert M, Williamson D, Meade M, Granton J, et al; Canadian Critical Care Trials Group. The 4Ts scoring system for heparin-induced thrombocytopenia in medical-surgical intensive care unit patients. J Crit Care. 2010;25(2):287-93.